Showing 1 - 10 of 92,676
IPOs since 2012. Reduced compliance costs encourage innovation capital formation as biotech IPO volume increases 200% and …
Persistent link: https://www.econbiz.de/10012829465
The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge … norms that are considered legitimated to carry out innovation in the biotech field. …
Persistent link: https://www.econbiz.de/10014370414
Persistent link: https://www.econbiz.de/10012264996
Die biotechnologische Industrie zählt zu den Zukunftsbranchen mit hohen Wachstumspotentialen. Entsprechend hoch ist auch das Interesse politischer Akteure, die nationalen und regionalen Standortbedingungen für diese Zukunftsindustrien zu optimieren. In einer Situation, als Deutschland...
Persistent link: https://www.econbiz.de/10011378813
"This book specifically provides the reader with the methodologies necessary to create a successful life sciences start-up from initiation to exit. The readers gain an appreciation for the necessary data, partnership, and skills to be acquired and the constituencies that must be satisfied, along...
Persistent link: https://www.econbiz.de/10010466371
Persistent link: https://www.econbiz.de/10001550560
Persistent link: https://www.econbiz.de/10001487885
specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong … appropriabilty regime the optimal strategy is to license the innovation to an incumbent product firm. This paper argues by contrast … commercialize alone or to pursue a hybrid arrangement (called co-promotion) whereby it licenses the innovation but retains the …
Persistent link: https://www.econbiz.de/10010357556
Persistent link: https://www.econbiz.de/10010260137
Persistent link: https://www.econbiz.de/10010417461